Sat.Apr 01, 2017 - Fri.Apr 07, 2017

article thumbnail

When Approval for a Drug “Indication” Gets Murky: Drafting Milestones to Avoid Disputes

Cooley M&A

According to a recent study by SRS of recent private life sciences deals, disputes over earn-outs arose in about one-third (36%) of all milestones that were expected to be hit by September 2016. [1] While most disputes were not about contract interpretation issues regarding whether an event triggered the milestone or not, [2] one recent dispute in the Delaware Court of Chancery illustrates the potentially significant value at stake when these interpretation issues do occur.

article thumbnail

2017 M&A Source Spring Conference

Burch & Co.

DATES: May 8th through the 10th. . Please let us know if you are in the Dallas/Ft. Worth area or will be attending M&A Source and would like to discuss how Burch & Company’s services can fit into your practice. We will be meeting with M&A Advisors, Investment Bankers and Intermediaries, as well as Private Equity groups while attending this conference.